1
0
Ministers of Health and government representatives from 9 African countries today agreed on joint measures to stop the potential spread of the ongoing Ebola disease outbreak in Uganda and beyond its borders.
An assessment conducted by World Health Organization (WHO) found that the risk of the Sudan ebolavirus spreading to neighbouring countries as high due to cross border movements between Uganda and other countries. The population is mobile due to trade, social and cultural connections. In addition, the country hosts many refugees who continue to keep ties with their countries of origin.
Recognizing the importance of collaborative efforts, the Government of Uganda, with support from the Africa Centres for Disease Control and Prevention (Africa CDC) and WHO today hosted a High-Level Emergency Ministerial meeting on Cross Border Collaboration for Preparedness and Response to Ebola Disease Outbreaks in Kampala.
The meeting concluded with a communique in which Ministers of Health and senior government officials from Burundi, the Democratic Republic of the Congo, Kenya, Liberia, Rwanda, Sierra Leone, South Sudan, Tanzania and Uganda endorsed key measures to prevent the cross-border spread of the Sudan Ebolavirus. These include disease surveillance, contact tracing and monitoring, prompt alert notification, information sharing and joint trainings of emergency responders, as well as carrying out simulation exercises to enhance preparedness and response.
“Uganda has experience in managing epidemics and since the beginning of this Ebola outbreak, with the support of our partners, we have taken measures to limit the transmission of the disease. Sharing experience and strengthening collaboration between our countries will enable us to respond quickly and efficiently to health emergencies affecting our countries,” said Hon Dr Jane Ruth Aceng Acero, Uganda’s Minister of Health.
The outbreak has affected five districts, and as of 12 October 2022, 54 confirmed cases and 19 deaths have been reported
Uganda declared an outbreak of the Sudan ebolavirus on 20 September 2022, marking the first time this species – one of the six under the Ebolavirus genus – was detected in the country since 2012.
“One of the crucial lessons Africa has learnt from previous Ebola outbreaks is that by uniting, we stay a step ahead of the virus. Through sharing information and resources, countries can go from firefighting to building an outbreak firewall and halting the spread of infections,” said Dr Matshidiso Moeti, WHO Regional Director for Africa. “The joint efforts agreed upon today place Uganda and the region on the road to breaking Ebola’s grip.”
The outbreak has affected five districts, and as of 12 October 2022, 54 confirmed cases and 19 deaths have been reported. With the intensifying response, more than a thousand contacts have been identified, while 20 people have recovered from the disease.
“We as a continent must work together to plan, prepare and respond to the Ebola outbreak and other public health threats through resource sharing, regional efforts to build resilience capacity of human resources, strengthening laboratory systems, surveillance, treatment and care,” said Dr Ahmed Ogwell Ouma, Acting Director General of the Africa CDC, emphasizing the need for collaboration efforts in ensuring health security of the Eastern Africa region and beyond. He also called for action to support the implementation of the Africa New Public Health Order.
The Ministers of Health also agreed on joint plans to carry out cross-border readiness, including raising public awareness and conducting community engagement campaigns. They also agreed to the rapid cross-border deployment of medical personnel to tackle the disease.
As no effective vaccine against the Sudan ebolavirus has been licenced yet, Ugandan health authorities have focused on supportive care for confirmed cases alongside stepping up testing, surveillance, infection prevention and control, as well as collaborating with communities to support disease prevention measures.
There are at least six candidate vaccines against Sudan ebolavirus, which are in different stages of development. Three of them have Phase1 data (safety and immunogenicity data in humans), and the remaining are in the preclinical evaluation phase.
About Author
OTHER ARTICLES
Zambia : The vital role of community health assistants in public health surveillance
Lusaka — African health ministers and partners are calling for increased investment in integrated health services to address the growing burden of severe noncommunicable diseases (NCDs), particularly those affecting women and underserved populations across the region. At a high-level side event during the Seventy-fifth session of the WHO Regional Committee for Africa, delegates emphasized the urgent need for equitable access to prevention, screening, treatment, and rehabilitation across the continuum of care for NCDs. Disparities are especially pronounced in rural areas, where health infrastructure and services remain inadequate. Breast and cervical cancers are among the leading causes of cancer-related deaths among women in sub-Saharan Africa—particularly cervical cancer, which is both preventable and treatable. It remains the most common cause of cancer death for women in the region. In 2022, Africa accounted for nearly a quarter (23%) of the 76 000 global cervical cancer deaths. Meanwhile, severe NCDs such as Type 1 diabetes, sickle cell disease, and heart conditions claim more than half a million lives annually, including among children, adolescents, and young adults in some of the continent’s poorest communities. Inequitable access to health services continues to hinder efforts to reduce this burden. To improve cervical and breast cancer care in the region, urgent investment is needed in leadership, governance, and financing. Strengthening these foundations is critical in the current funding landscape. Advancements in strategic planning, healthcare infrastructure, workforce training, and—most importantly—equitable access to screening, diagnostic, and treatment services are essential. To address these challenges, WHO and its partners showcased successful integrated models such as the Women’s Integrated Care for Cancer Services (WICS), the BEAT Breast Cancer Project, and the PEN-Plus Strategy. WICS strengthens early detection, treatment, and integration of women’s cancer services into primary health care systems in Côte d’Ivoire, Kenya, and Zimbabwe. The BEAT Breast Cancer Project is a transformative multi-year initiative aimed at reducing breast cancer mortality among women in Tanzania and Ghana through early detection, timely diagnosis, and comprehensive treatment access. “PEN-Plus, WICS and the BEAT Breast Cancer Initiative are models for a new standard of care, rooted in equity, access and health justice. I urge countries to prioritize policies that embed these models into broader health system strengthening, said Dr Mohamed Janabi, WHO Regional Director for Africa”. Côte d’Ivoire offers a compelling example of progress, combining high HPV vaccination coverage—reaching over three million girls (91.4%)—with WICS-supported community-based screening campaigns to strengthen cervical cancer prevention. In Kenya, cervical cancer screening has been successfully integrated into national health services. “This gathering marks a pivotal moment to accelerate action for breast cancer prevention in Africa. We deeply value the leadership of the Ministries of Health of Ghana and Tanzania, and the steadfast support of the Pfizer Foundation in helping us achieve this milestone. The side event builds momentum for the policy prioritization of women’s cancers, partnerships to strengthen the broader women’s cancer ecosystem, and advance a health-systems approach to breast cancer prevention and management”, said Dr Somesh Kumar, Senior Director, Jhpiego. PEN-Plus expands access to care for severe NCDs at the district hospital level. Since its implementation, 20 countries in Africa have increased access to services for severe NCDs. Over 15 000 people are currently receiving treatment for chronic conditions such as sickle cell disease and Type 1 diabetes through PEN-Plus clinics.
Confirmed Case of Mpox in Senegal: Situation Update (as of August 27, 2025)